Their nature makes them ideal against pathogens that hide from immune cells, such as HIV.
Nanobodies On The Road To Curing Parkinson’s Disease
Mostly affecting those 60 years old and older, an estimated 7 to 10 million people worldwide have Parkinson’s Disease.
Research moves closer to a universal flu vaccine
Scientists from the Scripps Research Institute (TSRI) and Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have discovered a way to give antibodies the ability to fight a wide range of influenza subtypes. Their work has great potential to one day eliminate the need for repeated seasonal flu shots.